We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
342 hedge funds and large institutions have $2.22B invested in Ginkgo Bioworks in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 109 increasing their positions, 99 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
10% more repeat investments, than reductions
Existing positions increased: 109 | Existing positions reduced: 99
0.09% more ownership
Funds ownership: 1.94% → 2.03% (+0.09%)
1% less capital invested
Capital invested by funds: $2.25B → $2.22B (-$26.3M)
9% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 47
2% less funds holding
Funds holding: 349 → 342 (-7)
20% less call options, than puts
Call options by funds: $6.11M | Put options by funds: $7.6M
Holders
342
Holders Change
-7
Holders Change %
-2.01%
% of All Funds
4.99%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
43
Increased
109
Reduced
99
Closed
47
Calls
$6.11M
Puts
$7.6M
Net Calls
-$1.49M
Net Calls Change
-$1.61M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$73.7M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$25.1M |
| 3 |
State Street
Boston,
Massachusetts
|
+$5.51M |
| 4 |
VAS
Vestmark Advisory Solutions
Wakefield,
Massachusetts
|
+$4.57M |
| 5 |
EAM
Erste Asset Management
Vienna,
Austria
|
+$3.66M |
Top Sellers
| 1 |
Schroder Investment Management Group
London,
United Kingdom
|
-$13.4M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$3.85M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.72M |
| 4 |
BHCM
Boulder Hill Capital Management
New York
|
-$2.65M |
| 5 |
HF
HRT Financial
New York
|
-$2.23M |
